Checkmate Pharmaceuticals (CMPI) PT Lowered to $19 at Jefferies After IDRA Top Line Miss
Tweet Send to a Friend
Jefferies analyst Maury Raycroft lowered the price target on Checkmate Pharmaceuticals (NASDAQ: CMPI) to $19.00 (from $23.00) after Idera Pharma's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
